Apotransferrin induces cAMP/CREB pathway and cell cycle exit in immature oligodendroglial cells

Journal of Neuroscience Research

Volumn 78, Issue 3, 2004, Pages 338-346

  Garcia, C ^a,b   Paez, P ^a,b   Davio, C ^b   Soto, E F ^a,b   Pasquini, Juana M ^a,b  

^a Facultad de Ciencias Naturales e Instituto M Lillo   (Argentina)

^b UNIVERSIDAD DE BUENOS AIRES   (Argentina)

Author keywords

Apotransferrin; cAMP; Cell cycle; CREB; Differentiation; Oligodendrocyte

Indexed keywords

APOTRANSFERRIN; BROXURIDINE; CYCLIC AMP; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; CYCLIN D1; DNA; GLYCOPROTEIN; PROTEIN P27;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELL CYCLE; CELL DIFFERENTIATION; CELL ISOLATION; CELL MATURATION; CELL POPULATION; CONTROLLED STUDY; DENSITY GRADIENT; DNA BINDING; GENE INDUCTION; IN VITRO STUDY; MYELINATION; NONHUMAN; OLIGODENDROGLIA; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RAT; SECOND MESSENGER;

AGE FACTORS; ANIMALS; ANIMALS, NEWBORN; APOPROTEINS; BLOTTING, WESTERN; BROMODEOXYURIDINE; CELL CYCLE; CELLS, CULTURED; CYCLIC AMP; CYCLIC AMP RESPONSE ELEMENT-BINDING PROTEIN; CYCLIN D1; CYCLIN E; DOSE-RESPONSE RELATIONSHIP, DRUG; ELECTROPHORETIC MOBILITY SHIFT ASSAY; HUMANS; IMMUNOHISTOCHEMISTRY; MYELIN BASIC PROTEINS; OLIGODENDROGLIA; RATS; SIGNAL TRANSDUCTION; TIME FACTORS; TRANSFERRIN;

EID: 8444250689     PISSN: 03604012     EISSN: None     Source Type: Journal    
DOI: 10.1002/jnr.20254     Document Type: Article

References (48)

1. Afshari FS, Chu AK, Sato-Bigbee C. 2001. Effect of cyclic AMP on the expression of myelin basic protein species and myelin proteolipid protein in committed oligodendrocytes: differential involvement of the transcription factor CREB. J Neurosci Res 66:37-45.
2. Belachew S, Aguirre AA, Wang H, Vautier F, Yuan X, Anderson S, Kirby M, Gallo V. 2002. Cyclin-dependent kinase-2 controls oligodendrocyte progenitor cell cycle progression and is downregulated in adult oligodendrocyte progenitors. J Neurosci 22:8553-8562.
3. Berti-Mattera LN, Larocca JN, Pellegrino de Iraldi A, Pasquini JM, Soto EF. 1984. Isolation of oligodendroglial cells from young and adult whole rat brains using an in situ generated Percoll density gradient. Neurochem Int 6:41-50.
4. Bradford MM. 1976. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72:248-254.
5. Casaccia-Bonnefil P, Liu A. 2003. Relationship between cell cycle molecules and onset of oligodendrocyte differentiation. J Neurosci Res 72:1-11.
6. Casaccia-Bonnefil P, Tikoo R, Kiyokavva H, Friedrich V Jr, Chao MV, Koff A. 1997. Oligodendrocyte precursor differentiation is perturbed in the absence of cyclin-dependent kinase inhibitor p27Kip1. Genes Dev 11:2335-2346.
7. Connor JR, Fine RE. 1987. The distribution of transferrin immunoreactivity in the rat nervous system. Brain Res 368:319-328.
8. Davio CA, Cricco GP, Bergoc RM, Rivera ES. 1995. H1 and H2 histamine receptors in N-nitroso-N-methylurea (NMU)-induced carcinomas with atypical coupling to signal transducers. Biochem Pharmacol 50:91-96.
9. Durand B, Gao FB, Raff M. 1997. Accumulation of the cyclin-dependent kinase inhibitor p27/Kip1 and the timing of oligodendrocyte differentiation. EMBO J 16:306-317.
10. Elledge SJ. 1996. Cell cycle checkpoints: preventing an identity crisis. Science 274:1664-1672.
11. Escobar Cabrera OE, Bongarzone ER, Soto EF, Pasquini JM. 1994. Single intracerebral injection of apotransferrin in young rats induces increased myelination. Dev Neurosci 16:248-254.
12. Escobar Cabrera OE, Zakin MM, Soto EF, Pasquini JM. 1997. Single intracranial injection of apotransferrin in young rats increases the expression of specific myelin protein mRNA. J Neurosci Res 47:603-608.
13. Escobar Cabrera OE, Soto EF, Pasquini JM. 2000. Myelin membranes isolated from rats intracranially injected with apotransferrin are more susceptible to in vitro peroxidation. Neurochem Res 25:87-93.
14. Espinosa de los Monteros A, Kumar S, Zhao P, Huang CJ, Nazarian R, Pan T, Scully S, Chang R, de Vellis J. 1999. Transferrin is an essential factor for myelination. Neurochem Res 24:235-248.
15. Espinosa-Jeffrey A, Kumar S, Zhao PM, Awosika O, Agbo C, Huang A, Chang R, de Vellis J. 2002. Transferrin regulates transcription of the MBP gene and its action synergizes with IGF-1 to enhance myelinogenesis in the md rat. Dev Neurosci 24:227-241.
16. Friessen AJ, Miskimins WK, Miskimins R. 1997. Cyclin-dependent kinase inhibitor p27kip1 is expressed at high levels in cells that express a myelinating phenotype. J Neurosci Res 50:373-382.
17. Garcia CI, Paez PM, Soto EF, Pasquini JM. 2003. In vivo and in vitro effects of apotransferrin on oligodendroglial maturation. Glia 42:406-416.
18. Ghiani C, Gallo V. 2001. Inhibition of cyclin E-cyclin-dependent kinase 2 complex formation and activity is associated with cell cycle arrest and withdrawal in oligodendrocyte progenitor cells. J Neurosci 21:1274-1282.
19. Ginty DD, Bonni A, Greenberg ME. 1994. Nerve growth factor activates a Ras-dependent protein kinase that stimulates c-fos transcription via phosphorylation of CREB. Cell 77:713-725.
20. Goldman JE, Zerlin M, Newman S, Zhang L, Gensert J. 1997. Fate, determination and migration of progenitors in the postnatal mammalian CNS. Dev Neurosci 19:42-48.
21. Gonzalez GA, Yamamoto KK, Fischer WH, Karr D, Menzel P, Biggs W 3rd, Vale WW, Montminy MR. 1989. A cluster of phosphorylation sites on the cAMP-regulated nuclear factor CREB predicted by its sequence. Nature 337:749-752.
22. Laemmli UK. 1970. Cleavage of structural protein during the assembly of the head of bacteriophage T4. Nature 227:680-685.
23. Marta CB, Davio C, Pasquini LA, Soto EF, Pasquini JM. 2002. Molecular mechanisms involved in the actions of apotransferrin upon the central nervous system: role of the cytoskeleton and of second messengers. J Neurosci Res 69:488-496.
24. Marta CB, Escobar Cabrera OE, Garcia CI, Villar MJ, Pasquini JM, Soto EF. 2000. Oligodendroglial cell differentiation in rat brain is accelerated by the intracranial injection of apotransferrin. Cell Mol Biol (Noisy-legrand) 46:529-539.
25. Mash DC, Pablo J, Flynn DD, Efange SM, Weiner WJ. 1990. Characterization and distribution of transferrin receptors in the rat brain. J Neurochem 55:1972-1979.
26. McMorris FA. 1983. Cyclic AMP induction of the myelin enzyme 2′,3′-cyclic nucleotide 3′-phosphohydrolase in rat oligodendrocytes. J Neurochem 41:506-515.
27. Miller RH. 1996. Oligodendrocyte origins. Trends Neurosci 19:92-96.
28. Montminy MR, Gonzalez GA, Yamamoto K. 1990. Regulation of cAMP-inducible genes by CREB. Trends Neurosci 13:184-188.
29. Oberhammer F, Fritsch G, Schmied M, Pavelka M, Printz D, Purchio T, Lassmann H, Schuhe-Hermann R. 1993. Condensation of the chromatin at the membrane of an apoptotic nucleus is not associated with activation of an endonuclease. J Cell Sci 104:317-326.
30. Ohnuma S, Philpott A, Harris WA. 2001. Cell cycle and cell fate in the nervous system. Curr Opin Neurobiol 11:66-73.
31. Paez P, Marta C, Besio Moreno M, Soto EF, Pasquini JM. 2002. Apotransferrin decreases migration and enhances differentiation of oligodendroglial progenitor cells in an in vitro system. Dev Neurosci 24:47-58.
32. Pende M, Fisher TL, Simpson PB, Russell JT, Blenis J, Gallo V. 1997. Neurotransmitter- and growth factor-induced cAMP response element binding protein phosphorylation in glial cell progenitors: role of calcium ions, protein kinase C, and mitogen-activated protein kinase/ribosomal S6 pathway. J Neurosci 17:1291-1301.
33. Pfeiffer SE, Warrington AE, Bansal R. 1993. The oligodendrocyte and its many cellular processes. Trends Cell Biol 3:191-197.
34. Pleasure D, Parris J, Stern J, Grinspan J, Kim SU. 1986. Incorporation of tritiated galactose into galactocerebroside by cultured rat oligodendrocytes: effects of cyclic adenosine 3′,5′-monophosphate analogues. J Neurochem 46:300-302.
35. kip1, a cyclin-cdk inhibitor and potential mediator of extracellular antimitogenic signals. Cell 78:59-66.
36. Raible DW, McMorris FA. 1989. Cyclic AMP regulates the rate of differentiation of oligodendrocytes without changing the lineage commitment of their progenitors. Dev Biol 133:437-446.
37. Raible DW, McMorris FA. 1990. Induction of oligodendrocyte differentiation by activators of adenylate cyclase. J Neurosci Res 27:43-46.
38. Sato-Bigbee C, Yu RK. 1993. Presence of a cyclic AMP response element-binding protein in oligodendrocytes. J Neurochem 60:2106-2110.
39. Sato-Bigbee C, Chan ELP, Yu RK. 1994. Oligodendroglial cyclic AMP response element-binding protein: a member of the CREB family of transcription factors. J Neurosci Res 38:621-628.
40. Sato-Bigbee C, De Vries GH. 1996. Treatment of oligodendrocytes with antisense deoxyoligonucleotide directed against CREB mRNA: effect on the cyclic AMP-dependent induction of myelin basic protein expression. J Neurosci Res 46:98-107.
41. Sato-Bigbee C, Pal S, Chu AK. 1999. Different neuroligands and signal transduction pathways stimulate CREB phosphorylation at specific developmental stages along oligodendrocyte differentiation. J Neurochem 72:139-147.
42. 2+- regulated transcription factor phosphorylated by calmodulin-dependent kinases. Science 252:1427-1430.
43. Sherr CJ, Roberts JM. 1995. Inhibitors of mammalian G1 cyclin-dependent kinases. Genes Dev 9:1149-1163.
44. Tokumoto YM, Tang DG, Raff MC. 2001. Two molecularly distinct pathways to oligodendrocyte differentiation: role of a p53 family protein. EMBO J 20:5261-5268.
45. Xie H, Rothstein TL. 1995. Protein kinase C mediates activation of nuclear cAMP response element-binding protein (CREB) in lymphocytes stimulated through surface Ig. J Immunol 154:1717-1723.
46. Xing J, Ginty D, Greenberg ME. 1996. Coupling of the Ras-MAPK pathway to gene activation by RSK2, a growth factor-regulated CREB kinase. Science 273:959-963.
47. Yamamoto KK, Gonzalez GA, Biggs WH 3rd, Montminy MR. 1988. Phosphorylation-induced binding and transcriptional efficacy of nuclear factor CREB. Nature 334:494-498.
48. Young SP, Bomford A, Williams R. 1984. The effect of the iron saturation of transferrin on its binding and uptake by rabbit reticulocytes. Biochem J 219:505-510.